Microsoft Corporation (MSFT) Office 365 Blows Into Windy City

Page 1 of 2

Microsoft Corporation (NASDAQ:MSFT) did have a time not too long ago when there was virtually no competition for its enterprise and government digital infrastructure. When it came to business networks, academic institutions and government agencies, Microsoft was the clear choice among IT professionals for their workstations and servers. But in the last couple of years, Google Inc. (NASDAQ:GOOG) introduced Google Apps to provide an alternative for cloud computing in enterprise and government spaces, and it had made some serious inroads.

GREENLIGHT CAPITAL

That is why the City of Chicago is a large battleground for both companies. And word is, Microsoft Corporation (NASDAQ:MSFT) has won that battle. So will it win the war, maintain its enterprise dominance and continue to be a blue-chip tech winner for investors like billionaire David Einhorn of Greenlight Capital?

With the blessing of Mayor Rahm Emanuel, who has committed to improving government efficiency in the city, the City of Chicago recently agreed to switch its 30,000 city employees to Microsoft Corporation (NASDAQ:MSFT) and its Office 365 cloud-computing software and services, choosing it over Google Apps among others. In announcing the agreement, Michael Donlan of Microsoft wrote in a blog post that Chicago is the latest of several U.S. cities that have seen the value of using Office 365 and it cloud capabilities in enterprise environments.

Once fully implemented, Microsoft Corporation (NASDAQ:MSFT) estimates that Office 365 will save Chicago city taxpayers about $400,000 annually. ┬áThe new system will apply to all e-mail and desktop applications across all departments – under the current system, Chicago has three different internal e-mail systems, for example. It is expected, then, that consolidation would improve efficiency and security across all offices of city government, making government more responsive. Now that we’ve heard from Microsoft, what does the City of Chicago have to say?

Page 1 of 2

Biotech Insider Alert - $5 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.
X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 129% in 2.5 years!! Wondering How?

Download a complete edition of our newsletter for free!